Aliskiren, a novel orally effective renin inhibitor, provides antihypertensive efficacy and placebo-like tolerability similar to an at1-receptor blocker in hypertensive patients

✍ Scribed by Alan H. Gradman; Roland E. Schmieder; Robert L. Lins; Yanntong Chiang; Martin P. Bedigian

• Book ID: 116207941
• Publisher: Nature Publishing Group
• Year: 2004
• Tongue: English
• Weight: 42 KB
• Volume: 17
• Category: Article
• ISSN: 0895-7061
• DOI: 10.1016/j.amjhyper.2004.03.279